Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024 - Seite 2

The Medacta 25^th Anniversary celebration included the successful 10^th M.O.R.E. International Symposium held in Switzerland, in April, followed by a World Tour hosting a series of global scientific events in Australia and the US. These events brought together renowned experts to share knowledge with other surgeons about the sustainability of personalized medicine, and our latest technological innovations in orthopedics and spine surgery. For Knee, there has been a particular focus on Kinematic Alignment (KA), a personalized and innovative technique intended to increase patient satisfaction, together with the initial results of GMK SpheriKA, the world’s first implant specifically designed for this technique.

Supply chain remains a key factor to sustain the continued solid growth of the company and the expansion of our facilities in Switzerland is progressing as planned.

Revenue by geography

Positive performance was recorded in every market headed by strong growth in EMEA, along with continuous progress in North America and APAC. In every region the increase was sustained by a continued expansion of our salesforce and customer base, together with some new products introduction, particularly in the Knee business line through GMK SpheriKA.

Below we report the 1H 2024 sales break-down by geographic area:

(Million Euro)	1H 2024	1H 2023	Reported Growth	Constant Currency Growth
EMEA	144.2	123.1	17.2%	16.6%
North America	84.9	76.5	11.1%	11.1%
Asia Pacific	54.3	51.4	5.7%	12.6%
Latin America*	5.2	4.2	22.3%	22.3%
TOTAL	288.6	255.1	13.1%	14.3%

* Latin America (LATAM): includes revenue from countries located in Latin America which were previously named RoW.